Subjects will receive tazemetostat as dictated in their antecedent study. research hub

TAZEMETOSTAT ROLLOVER STUDY (TRUST): AN OPEN-LABEL, ROLLOVER STUDY

This study is for people who have already taken part in a trial for a cancer drug called tazemetostat. It's designed to keep giving them the drug and closely watch their health to see how safe it is and how well they tolerate it over a longer time.